Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?

Sameer Bhimani; Hiba Khalid; Momina Khalid; Rohan Kumar Ochani

doi:10.5812/ijem.107669

Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?

authors:

Sameer Bhimani ¹ , Hiba Khalid ² , Momina Khalid ¹ , Rohan Kumar Ochani ^{2
, *}

1 Jinnah Sindh Medical University, Karachi, Pakistan

2 Dow University of Health Sciences, Karachi, Pakistan

International Journal of Endocrinology and Metabolism: Vol.18, issue 3; e107669

published online: August 25, 2020

article type: Letter

received: July 19, 2020

revised: August 10, 2020

accepted: August 16, 2020

DOI: https://doi.org/10.5812/ijem.107669

how to cite: Bhimani S, Khalid H, Khalid M, Ochani R K. Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?. Int J Endocrinol Metab. 2020;18(3):e107669. https://doi.org/10.5812/ijem.107669.

Keywords

Coronavirus Disease 2019 COVID-19 Biomarkers Vitamin D Vitamin D Deficiency

Footnotes

Authors' Contribution: Study concept and design: SB, HK, MK, and RO. Drafting of the manuscript: SB, HK, MK, and RO. Critical revision of the manuscript for important intellectual content: SB, HK, MK, and RO. Approval of the final version of the manuscript: SB, HK, MK, and RO.
Conflict of Interests: The authors declare no conflict of interest to declare.
Funding/Support: The authors received no funding or support to perform the current study.

References

1.
Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. J Immunol. 2008;181(10):7090-9. [PubMed ID: 18981129]. [PubMed Central ID: PMC2596683]. https://doi.org/10.4049/jimmunol.181.10.7090.
2.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4). [PubMed ID: 32252338]. [PubMed Central ID: PMC7231123]. https://doi.org/10.3390/nu12040988.
3.
Hadizadeh F. Supplementation with vitamin D in the COVID-19 pandemic? Nutr Rev. 2020. [PubMed ID: 32679589]. https://doi.org/10.1093/nutrit/nuaa081.
4.
Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020;12(4). e7560. [PubMed ID: 32269893]. [PubMed Central ID: PMC7138423]. https://doi.org/10.7759/cureus.7560.
5.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020. [PubMed ID: 32648899]. https://doi.org/10.1001/jama.2020.12839.
6.
D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R, et al. 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020;12(5). [PubMed ID: 32397511]. [PubMed Central ID: PMC7285131]. https://doi.org/10.3390/nu12051359.
7.
Sizar O, Khare S, Goyal A, Bansal P, Givler A. Vitamin D deficiency. StatPearls. Treasure Island (FL); 2020. eng.
8.
Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation: Potential implications for severity of covid-19. Ir Med J. 2020;113(5):81. [PubMed ID: 32603576].
9.
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 2017;356. i6583. [PubMed ID: 28202713]. [PubMed Central ID: PMC5310969]. https://doi.org/10.1136/bmj.i6583.

comments